DPS Parmar of LexOrbis considers the wealth of case law in which prosecution history estoppel has helped to adjudicate on patent issues, and explains the implications for patentees
In a first-of-its-kind judgment, the Delhi High Court has refused to grant an interim injunction against the defendants, stating that their process did not infringe the plaintiff’s patent that had constituted a ‘product-by-process’ claim. The patent community is hoping for a more detailed order after the trial, as this will provide much-needed clarity on the scope of product-by-process claims.
The Delhi High Court said third parties who use different processes to make a patented product can’t be restricted if the plaintiff’s registration covers a product-by-process patent
/PRNewswire/ The "Osteoarthritis Therapeutics Market Analysis by Anatomy, by Drug Type, by Route of Administration, by Purchasing Pattern by Distribution.
Acute lymphoblastic leukaemia is the most common kind of childhood cancer but the drugs containing asparaginase are of poor quality, leaving 70 000 children at risk